Son güncelleme :
19/11/2024
Infostab
Listeler
Listeler
Uyumluluk arayın
Y site uyumluluk tablosu
Kaynaklar
Araştırma Takımlar
valistab
afiş
Bağlantıları
sponsorlar
Yazar
Kullanıcı rehberi
Bültenini
Araştırma Takımlar - University of Southern california, School of Pharmacy
University of Southern california, School of Pharmacy
Los Angeles
Kaynaklar
(20)
1
Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
Chin A, Liu S, Ting-Chan J, Gill MA. ()
Am J Health-Syst Pharm -
2005
- ; 62: 1073-1074.
2
Stability and antibacterial activity of cefepime during continuous infusion.
Sprauten PF, Beringer PM, Louie ST, Synold TW, Gill MA. ( beringer@usc.edu)
Antimicrob Agents Chemother -
2003
- ; 47: 1991-1994.
3
Stability of irinotecan hydrochloride in aqueous solutions.
Li WY, Koda RT. (mppugari@hsc.usc.edu)
Am J Health-Syst Pharm -
2002
- ; 59: 539-544.
4
Activity of dalteparin sodium in polypropylene syringes.
Louie S, Chin A, Gill MA. (mgill@hsc.usc.edu)
Am J Health-Syst Pharm -
2000
- ; 57: 760-762.
5
Stability of sumatriptan succinate in polypropylene syringes.
Nii LJ, Chin A, Cao TM, Gill MA. ()
Am J Health-Syst Pharm -
1999
- ; 56: 983-985.
6
Five-day stability of vinorelbine in 5% dextrose injection and in 0.9% sodium chloride injection at room temperature.
Lieu CL, Chin A, Gill MA. ()
Int J Pharm Compound -
1999
- ; 3: 67-68.
7
Stability of milrinone lactate 200 microg /mL in 5% dextrose injection and 0.9% sodium chloride injection.
Wong F, Gill MA. ()
Int J Pharm Compound -
1998
- ; 2: 168-169.
8
Stability of milrinone lactate in 5% dextrose injection and 0.9% sodium chloride injection at concentrations of 400, 600 and 800 microg/mL.
Nguyen D, Gill MA, Wong F. ()
Int J Pharm Compound -
1998
- ; 2: 246-248.
9
Stability of granisetron hydrochloride with dexamethasone sodium phosphate for 14 days.
Chin A, Moon YSK, Chung KC, Gill MA. ()
Am J Health-Syst Pharm -
1996
- ; 53: 1174-1176.
10
Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration.
Chung KC, Moon YSK, Chin A, Ulrich WU, Gill MA. ()
Am J Health-Syst Pharm -
1995
- ; 52: 1554-1556.
11
Stability of granisetron hydrochloride in a disposable elastomeric infusion device.
Chung KC, Chin A, Gill MA. ()
Am J Health-Syst Pharm -
1995
- ; 52: 1541-1543.
12
Stability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibags.
Moon YSK, Chung KC, Chin A, Gill MA. ()
Am J Health-Syst Pharm -
1995
- ; 52: 999-1001.
13
Stability of piperacillin sodium-tazobactam sodium in peritoneal dialysis solutions
Park TW, Le-Bui LP, Chung KC, Rho JP, Gill MA. ()
Am J Health-Syst Pharm -
1995
- ; 52: 2022 - 2024.
14
Stability of ranitidine hydrochloride with ondansetron hydrochloride or fluconazole during simulated Y-site administration.
Pompilio FM, Fox JL, Inagaki K, Burm JP, Jhee S, Gill MA. ()
Am J Hosp Pharm -
1994
- ; 51: 391-394.
15
Stability of paclitaxel and fluconazole during simulated Y-site administration.
Burm JP, Choi JS, Jhee SS, Chin A, Ulrich RW, Gill MA. ()
Am J Hosp Pharm -
1994
- ; 51: 2704-2706.
16
Stability of paclitaxel with ondansetron or ranitidine hydrochloride during simulated Y site administration.
Burm JP, Jhee SS, Chin A, Moon YSK. ()
Am J Hosp Pharm -
1994
- ; 51: 1201-1204.
17
Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
Choi JS, Burm JP, Jhee SS, Chin A, Ulrich RW, Gill MA. ()
Am J Hosp Pharm -
1994
- ; 51: 2273-2276.
18
Stability of ondansetron hydrochloride stored in a disposable, elastomeric infusion device at 4°C.
Jhee SS, Jeong EW, Chin A, Inagaki K, Fox JL, Gill MA. ()
Am J Hosp Pharm -
1993
- ; 50: 1918-1920.
19
Visual compatibility of ciprofloxacin with selected components of total parenteral nutrient solutions during simulated Y-site injection.
Percy LA, Rho JP. ()
Am J Hosp Pharm -
1993
- ; 50: 715-716.
20
Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
Inagaki K, Gill MA, Okamoto MP, Takagi J. ()
J Parenter Sci Technol -
1993
- ; 47: 35-39.
moleküller okudu
(21)
Ascorbic acid
Calcium gluconate
Cefepime dihydrochloride
Cefmetazole sodium
Ciprofloxacin lactate
Dalteparin sodium
Dexamethasone sodium phosphate
Fluconazole
Granisetron hydrochloride
Irinotecan
Magnesium sulfate
Milrinone lactate
Ondansetron hydrochloride
Paclitaxel
Piperacillin sodium / tazobactam
Potassium chloride
Potassium phosphate
Ranitidine hydrochloride
Sodium Phosphate
Sumatriptan succinate
Vinorelbine tartrate
Mentions Légales